Nephro-Urology Monthly

Published by: Kowsar

Effects of Clopidogrel on Longevity of Permanent Double-Lumen Catheter Patency in Dialysis Patients: A Single-Blind Placebo-Controlled Clinical Trial

Mohamad Mozafar 1 , Majid Alborzi 1 , * and Arash Moradi 1
Authors Information
1 Shohada-e Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
Article information
  • Nephro-Urology Monthly: March 2018, 10 (2); e58135
  • Published Online: February 20, 2018
  • Article Type: Research Article
  • Received: August 9, 2017
  • Revised: October 16, 2017
  • Accepted: February 3, 2018
  • DOI: 10.5812/numonthly.58135

To Cite: Mozafar M, Alborzi M, Moradi A. Effects of Clopidogrel on Longevity of Permanent Double-Lumen Catheter Patency in Dialysis Patients: A Single-Blind Placebo-Controlled Clinical Trial, Nephro-Urol Mon. 2018 ;10(2):e58135. doi: 10.5812/numonthly.58135.

Abstract
Copyright © 2018, Nephro-Urology Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Methods
3. Results
4. Discussion
References
  • 1. Beigi AA, HadiZadeh MS, Salimi F, Ghaheri H. Heparin compared with normal saline to maintain patency of permanent double lumen hemodialysis catheters: A randomized controlled trial. Adv Biomed Res. 2014;3:121. doi: 10.4103/2277-9175.133192. [PubMed: 24949292].
  • 2. Moss AH, Vasilakis C, Holley JL, Foulks CJ, Pillai K, McDowell DE. Use of a silicone dual-lumen catheter with a Dacron cuff as a long-term vascular access for hemodialysis patients. Am J Kidney Dis. 1990;16(3):211-5. [PubMed: 2144708].
  • 3. Shaffer D, Madras PN, Williams ME, D'Elia JA, Kaldany A, Monaco AP. Use of Dacron cuffed silicone catheters as long-term hemodialysis access. ASAIO J. 1992;38(1):55-8. [PubMed: 1532515].
  • 4. Schenk P, Rosenkranz AR, Wolfl G, Horl WH, Traindl O. Recombinant tissue plasminogen activator is a useful alternative to heparin in priming quinton permcath. Am J Kidney Dis. 2000;35(1):130-6. doi: 10.1016/S0272-6386(00)70311-8. [PubMed: 10620554].
  • 5. Mozafar M, Samsami M, Sobhiyeh MR, Jabbehdari S, Fallah Zavareh M. Effectiveness of aspirin on double lumen permanent catheter efficacy in ESRD. Nephrourol Mon. 2013;5(2):762-5. doi: 10.5812/numonthly.8733. [PubMed: 23841041].
  • 6. Windus DW. Permanent vascular access: a nephrologist's view. Am J Kidney Dis. 1993;21(5):457-71. [PubMed: 8488813].
  • 7. Obialo CI, Conner AC, Lebon LF. Maintaining patency of tunneled hemodialysis catheters--efficacy of aspirin compared to warfarin. Scand J Urol Nephrol. 2003;37(2):172-6. doi: 10.1080/00365590310008938. [PubMed: 12745728].
  • 8. Northsea C. Using urokinase to restore patency in double lumen catheters. ANNA J. 1994;21(5):261-4. 273. [PubMed: 8080337].
  • 9. Meers C, Toffelmire EB. Urokinase efficacy in the restoration of hemodialysis catheter function. J CANNT. 1998;8(2):17-9. [PubMed: 9807329].
  • 10. Johnstone RD, Stewart GA, Akoh JA, Fleet M, Akyol M, Moss JG. Percutaneous fibrin sleeve stripping of failing haemodialysis catheters. Nephrol Dial Transplant. 1999;14(3):688-91. [PubMed: 10193820].
  • 11. Brady PS, Spence LD, Levitin A, Mickolich CT, Dolmatch BL. Efficacy of percutaneous fibrin sheath stripping in restoring patency of tunneled hemodialysis catheters. AJR Am J Roentgenol. 1999;173(4):1023-7. doi: 10.2214/ajr.173.4.10511171. [PubMed: 10511171].
  • 12. Lee M, Wu YL, Saver JL, Lee HC, Lee JD, Chang KC, et al. Is clopidogrel better than aspirin following breakthrough strokes while on aspirin? A retrospective cohort study. BMJ Open. 2014;4(12):6672. doi: 10.1136/bmjopen-2014-006672. [PubMed: 25468508].
  • 13. Deguchi N, Ohigashi T, Tazaki H, Handa M, Ikeda Y. Haemodialysis and platelet activation. Nephrol Dial Transplant. 1991;6 Suppl 2:40-2. [PubMed: 1714062].
  • 14. Viener A, Aviram M, Better OS, Brook JG. Enhanced in vitro platelet aggregation in hemodialysis patients. Nephron. 1986;43(2):139-43. doi: 10.1159/000183813. [PubMed: 3713942].
  • 15. Windus DW, Santoro SA, Atkinson R, Royal HD. Effects of antiplatelet drugs on dialysis-associated platelet deposition in polytetrafluoroethylene grafts. Am J Kidney Dis. 1997;29(4):560-4. [PubMed: 9100045].
  • 16. Harter HR, Burch JW, Majerus PW, Stanford N, Delmez JA, Anderson CB, et al. Prevention of thrombosis in patients on hemodialysis by low-dose aspirin. N Engl J Med. 1979;301(11):577-9. doi: 10.1056/NEJM197909133011103. [PubMed: 112475].
  • 17. Yasuda H, Matsuo Y, Sato Y, Ozawa S, Ishigooka S, Yamashita M, et al. Treatment and prevention of gastrointestinal bleeding in patients receiving antiplatelet therapy. World J Crit Care Med. 2015;4(1):40-6. doi: 10.5492/wjccm.v4.i1.40. [PubMed: 25685721].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments